Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow OptimizeRx Corp

Get SEC filing alerts via email and in your feed for OptimizeRx Corp

OPRX

OptimizeRx Corp

About OptimizeRx Corp

OptimizeRx Corporation is a healthcare technology company specializing in digital marketing solutions for the life sciences industry. It offers AI-driven audience targeting, omnichannel engagement, and patient and provider communication platforms. Serving pharmaceutical manufacturers and healthcare providers, it enhances brand visibility, patient access, and treatment support through proprietary data, privacy-safe targeting, and integrated digital channels. Its business model focuses on innovative, scalable solutions to improve healthcare marketing and patient outcomes.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from OptimizeRx Corp

1
1
OptimizeRx Corp OptimizeRx Reports $19.8 Million Revenue in Q1 2026, Down 10% Year-Over-Year

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
OptimizeRx Corp OptimizeRx Corporation Reports Financial Turnaround with $5.1 Million Net Income in 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
OptimizeRx Corp OptimizeRx Reports 22% Revenue Growth and Net Income Turnaround in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
OptimizeRx Corp OptimizeRx Reports 55% Revenue Growth to $29.2 Million in Latest Quarter

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
OptimizeRx Corp OptimizeRx Reports 11% Revenue Growth to $21.9 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
OptimizeRx Corp OptimizeRx Reports 29% Revenue Growth to $92.1 Million for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
OptimizeRx Corp OptimizeRx Reports 30% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments